Repairon Immuno GmbH

Business Description Repairon Immuno GmbH is a young startup with a mission to develop novel cell therapies to treat most challenging diseases. To achieve this goal, we will take advantage of exclusively licensed induced Pluripotent Stem Cell (iPSC) line, which is the only iPSC line being currently validated in European clinical trial. This cell line in combination with our proprietary, scalable, GMP-compliant differentiation platform as well as proprietary gene editing designs will enable us to generate never-done-before types of cell drug products. Moreover, using iPSCs as an initial cell source will allow to dramatically simplify manufacturing and significantly reduce therapy costs. Consequently, lower prices will enable treatment of previously overlooked indications, such as (rare) autoimmune disorders and less frequent cancers (e.g., T cell malignancies). We believe that with our products we will address unmet medical needs of patients.
Tags iPSC, cell therapy, CAR cells, autoimmune diseases
Website https://de.linkedin.com/company/repairon-immuno
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
Repairon Immuno GmbH? We're happy to assist you with our
Startup Sourcing service.